Triple
T6217726
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Hospital for Special Surgery |
E139030
|
entity |
| Predicate | hasClinicalProgram |
P6928
|
FINISHED |
| Object |
Scleroderma, Vasculitis, and Myositis Center
The Scleroderma, Vasculitis, and Myositis Center is a specialized clinical program at the Hospital for Special Surgery focused on the diagnosis, treatment, and research of complex autoimmune rheumatic diseases affecting connective tissues, blood vessels, and muscles.
|
E577133
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Scleroderma, Vasculitis, and Myositis Center | Statement: [Hospital for Special Surgery, hasClinicalProgram, Scleroderma, Vasculitis, and Myositis Center]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Scleroderma, Vasculitis, and Myositis Center Context triple: [Hospital for Special Surgery, hasClinicalProgram, Scleroderma, Vasculitis, and Myositis Center]
-
A.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
The National Institute of Arthritis and Musculoskeletal and Skin Diseases is a U.S. government biomedical research institute that conducts and supports research on arthritis, musculoskeletal disorders, and skin diseases.
-
B.
Duchossois Center for Advanced Medicine
The Duchossois Center for Advanced Medicine is a major outpatient care and specialty treatment facility within the University of Chicago’s medical campus, known for integrating advanced clinical services and research.
-
C.
NIH Clinical Center
The NIH Clinical Center is the research hospital of the U.S. National Institutes of Health, dedicated to conducting and supporting clinical studies that translate scientific discoveries into medical advances.
-
D.
Heart and Lung Research Institute
The Heart and Lung Research Institute is a major biomedical research center in Cambridge focused on advancing understanding and treatment of cardiovascular and respiratory diseases.
-
E.
Office of Rare Diseases Research
The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Scleroderma, Vasculitis, and Myositis Center Triple: [Hospital for Special Surgery, hasClinicalProgram, Scleroderma, Vasculitis, and Myositis Center]
Generated description
The Scleroderma, Vasculitis, and Myositis Center is a specialized clinical program at the Hospital for Special Surgery focused on the diagnosis, treatment, and research of complex autoimmune rheumatic diseases affecting connective tissues, blood vessels, and muscles.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Scleroderma, Vasculitis, and Myositis Center Target entity description: The Scleroderma, Vasculitis, and Myositis Center is a specialized clinical program at the Hospital for Special Surgery focused on the diagnosis, treatment, and research of complex autoimmune rheumatic diseases affecting connective tissues, blood vessels, and muscles.
-
A.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
The National Institute of Arthritis and Musculoskeletal and Skin Diseases is a U.S. government biomedical research institute that conducts and supports research on arthritis, musculoskeletal disorders, and skin diseases.
-
B.
Duchossois Center for Advanced Medicine
The Duchossois Center for Advanced Medicine is a major outpatient care and specialty treatment facility within the University of Chicago’s medical campus, known for integrating advanced clinical services and research.
-
C.
NIH Clinical Center
The NIH Clinical Center is the research hospital of the U.S. National Institutes of Health, dedicated to conducting and supporting clinical studies that translate scientific discoveries into medical advances.
-
D.
Heart and Lung Research Institute
The Heart and Lung Research Institute is a major biomedical research center in Cambridge focused on advancing understanding and treatment of cardiovascular and respiratory diseases.
-
E.
Office of Rare Diseases Research
The Office of Rare Diseases Research is a U.S. government program that coordinates and supports research, information, and collaboration efforts focused on rare diseases.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c008aecb0c81909984b48f733ce8ae |
completed | March 22, 2026, 3:20 p.m. |
| NER | Named-entity recognition | batch_69c062a35e308190be25c41b02704411 |
completed | March 22, 2026, 9:44 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c20db4e0ac8190ba7bca1f9d8ac6df |
completed | March 24, 2026, 4:06 a.m. |
| NEDg | Description generation | batch_69c20ff2bb188190baf8a849efc15f87 |
completed | March 24, 2026, 4:15 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69c21365f8f48190970555bd9593b5a4 |
completed | March 24, 2026, 4:30 a.m. |
Created at: March 22, 2026, 4:21 p.m.